Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D.

CONCLUSION: The ProMisE classification proved to be an efficient and easily implementable system. Future research should elucidate the precise biological and prognostic meaning of the cases with multiple molecular markers. PMID: 31980219 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31980219?dopt=Abstract

Source: Gynecologic Oncology - January 20, 2020 Category: Cancer & Oncology Authors: Timmerman S, Van Rompuy AS, Van Gorp T, Vanden Bempt I, Brems H, Van Nieuwenhuysen E, Han SN, Neven P, Victoor J, Laenen A, Vergote I Tags: Gynecol Oncol Source Type: research